Patents by Inventor Ana Bueno Melendo

Ana Bueno Melendo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amides as Bace Inhibitors
    Publication number: 20070225372
    Abstract: The present invention provides BRACE inhibitors of Formula (I): methods for their use, and intermediates and methods for their preparation.
    Type: Application
    Filed: April 8, 2005
    Publication date: September 27, 2007
    Inventors: Ana Bueno Melendo, Shu-Hui Chen, Jon Erickson, Maria Rosario Gonzalez-Garcia, Deqi Guo, Alicia Marcos Lorente, James McCarthy, Timothy Shepherd, Scott Sheehan, Yvonne Yip
  • 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors
    Publication number: 20070225267
    Abstract: The present invention provides BACE inhibitors of Formula (I); methods for their use and preparation, and intermediates useful for their preparation.
    Type: Application
    Filed: September 20, 2005
    Publication date: September 27, 2007
    Inventors: Howard Broughton, Robert Dally, Timothy Durham, Maria Rosario Gonzalez-Garcia, Lilly Sa, Patric Hahn, Kenneth Henry, Todd Kohn, James McCarthy, Timothy Shepherd, Jon Erickson, Ana Bueno Melendo
  • Isochroman compounds for treatment of cns disorders
    Publication number: 20050014750
    Abstract: This invention relates to compounds of formula (I) where R1 to R12, —W—V—, —X—Y—, p and n have the values defined in claim 1, their preparation and use as pharmaceuticals.
    Type: Application
    Filed: December 6, 2002
    Publication date: January 20, 2005
    Inventors: Javier Agejas-Chicharro, Graham Timms, Andrew Williams, Nicholas Camp, Jeremy Gilmore, Ana Bueno Melendo, Carlos Lamas-Peteira
  • Prodrugs of excitatory amino acids
    Publication number: 20050009912
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs of formula (I) wherein the residue R11, R12 and R13 are aas defined in claim 1. The invention further relates to processes for the preparation of the compounds of formula (I), and to pharmaceutical compositions for the treatment of neurological and psychiatric disorders comprising said compounds.
    Type: Application
    Filed: December 5, 2002
    Publication date: January 13, 2005
    Inventors: Ana Bueno Melendo, Alfonso De Dios, Carmen Dominguez-Fernandez, Rafael Ferritto Crespo, Jose Martin, Maria Martinez-Grau, Steven Massey, James Monn, Concepcion Pedregal-Tercero, Matthew Valli, Marc Herin